Nuvectis Pharma (NVCT) Cash & Equivalents (2021 - 2026)
Nuvectis Pharma (NVCT) posted Cash & Equivalents of $22.2 million for Q2 2026, down 17.2% from $26.8 million a year earlier and down 11.7% from the prior quarter.
Powered by 
Analysis
Nuvectis Pharma (NVCT) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Nuvectis Pharma's Cash & Equivalents came in at $31.63 million, up 70.7% from FY2024.
- Annual Cash & Equivalents shows a four-year compound annual growth rate of 53.2% (FY2021 to FY2025).
- In prior years, Nuvectis Pharma's Cash & Equivalents was $18.53 million in FY2024 (-3.1%), $19.13 million in FY2023 (-4.3%), $19.99 million in FY2022 (+248.2%) and $5.74 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q4 2024.
- On a year-over-year basis, Cash & Equivalents increased in four of the last eight quarters, with growth averaging 27.5%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2022, with growth of 248.2%; the weakest was Q2 2024, with a decline of 26.4%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $25.13 million (Q1 2026), $31.63 million (Q4 2025) and $35.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Nuvectis Pharma | 553.12 Mn | 553.12 Mn | - | 22.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.20 Mn |
| Mar 31, 2026 | 25.13 Mn |
| Dec 31, 2025 | 31.63 Mn |
| Sep 30, 2025 | 35.44 Mn |
| Jun 30, 2025 | 26.80 Mn |
| Mar 31, 2025 | 29.90 Mn |
| Dec 31, 2024 | 18.53 Mn |
| Sep 30, 2024 | 17.20 Mn |
| Jun 30, 2024 | 18.12 Mn |
| Mar 31, 2024 | 19.50 Mn |
| Dec 31, 2023 | 19.13 Mn |
| Sep 30, 2023 | 22.10 Mn |
| Jun 30, 2023 | 24.60 Mn |
| Mar 31, 2023 | 15.50 Mn |
| Dec 31, 2022 | 19.99 Mn |
| Sep 30, 2022 | 23.64 Mn |
| Jun 30, 2022 | 13.60 Mn |
| Mar 31, 2022 | 16.70 Mn |
| Dec 31, 2021 | 5.74 Mn |
API Access
Nuvectis Pharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();